myeloperoxidase.blogspot.com
MYELOPEROXIDASE RESEARCH: 09_01
http://myeloperoxidase.blogspot.com/2009_01_01_archive.html
Association of Major Depressive Disorder with Serum Myeloperoxidase and Other Markers of Inflammation: A Twin Study. MDD) has been linked to inflammation, but this association may be due to common precursors to both depression and inflammation. Myeloperoxidase. MPO) is an inflammatory enzyme produced by activated leukocytes. That predicts risk of coronary heart disease. We sought to examine whether MPO. Of inflammation included MPO. Interleukin-6, white blood cell count, C-reactive protein. V Vaccarino ,...
myeloperoxidase.blogspot.com
MYELOPEROXIDASE RESEARCH: 10_05
http://myeloperoxidase.blogspot.com/2010_05_01_archive.html
Myeloperoxidase Breaks Down Potentially Toxic Nanomaterials Identified. ScienceDaily (Apr. 8, 2010) — An international study based at the University of Pittsburgh provides the first identification of a human enzyme that can biodegrade carbon nanotubes-the superstrong materials found in products from electronics to plastics-and in laboratory tests offset the potentially damaging health effects of being exposed to the tiny components, according to findings published online in Nature Nanotechnology. Subscri...
myeloperoxidase.blogspot.com
MYELOPEROXIDASE RESEARCH: 10_03
http://myeloperoxidase.blogspot.com/2010_03_01_archive.html
Oxidation of apolipoprotein A-I by myeloperoxidase impairs the initial interactions with ABCA1 required for signaling and cholesterol export. A key cardioprotective effect of high-density lipoprotein. HDL) involves the interaction of its major protein, apolipoprotein. A-I (apoA-I), with ATP-binding cassette transporter A1 (ABCA1), a macrophage cholesterol exporter. ApoA I. Our results indicate that chlorination of apoA-I by the MPO pathway selectively inhibits two critical early events in cholesterol eff...
myeloperoxidase.blogspot.com
MYELOPEROXIDASE RESEARCH: 10_10
http://myeloperoxidase.blogspot.com/2010_10_01_archive.html
Myeloperoxidase, inflammation, and dysfunctional high-density lipoprotein. Journal of Lipidology: Volume 4, Issue 5, Pages 382-388 (September 2010). Links to this post. Myeloperoxidase, inflammation, and dysfunctional high-density lipoprotein. Journal of Lipidology: Volume 4, Issue 5, Pages 382-388 (September 2010). Links to this post. Subscribe to: Posts (Atom). Lee Biosolutions, Inc. The Cleveland Clinic Foundation. James J. Peters VA Medical Center Bronx. University of Michigan School Of Medicine.
tumormarkers.blogspot.com
CANCER RESEARCH: The Basis of Racial Differences in the Incidence of Thyroid Cancer
http://tumormarkers.blogspot.com/2008/02/basis-of-racial-differences-in.html
The Basis of Racial Differences in the Incidence of Thyroid Cancer. BACKGROUND: The incidence of thyroid cancer. In black Americans is half that in white Americans. It is unknown whether this gap represents a population difference in disease or is attributable to inferior cancer screening in the black population. 4 cm in size (RR 1.13, P. Posted by Research Proteins. Massachusetts Institute Of Technology. Lee Biosolutions, Inc. CANCER ANTIGEN CA 125. CANCER ANTIGEN CA 50. CANCER ANTIGEN CA 72-4.
tumormarkers.blogspot.com
CANCER RESEARCH: NTU discovery may help cardiovascular, cancer experiments
http://tumormarkers.blogspot.com/2008/01/ntu-discovery-may-help-cardiovascular.html
NTU discovery may help cardiovascular, cancer experiments. A research team at National Taiwan University (NTU) has discovered a gene that curbs liver cancer metastasis and another that triggers coronary artery disease, the team's instructor said yesterday. Lin said the team's discovery would help in developing new medicine and designing clinical experiments for liver cancer and cardiovascular disease. In addition, the team found that the thromboxane A2 gene, or TXA2, causes coronary artery narrowing....
tumormarkers.blogspot.com
CANCER RESEARCH: Therapeutic antibodies for the treatment of pancreatic cancer.
http://tumormarkers.blogspot.com/2010/09/therapeutic-antibodies-for-treatment-of.html
Therapeutic antibodies for the treatment of pancreatic cancer. Chames P, Kerfelec B, Baty D. INSERM U624, GDR2352, Marseille Cedex, France. Posted by Research Proteins. Massachusetts Institute Of Technology. Lee Biosolutions, Inc. CANCER ANTIGEN CA 125. CANCER ANTIGEN CA 50. CANCER ANTIGEN CA 72-4. CANCER ANTIGEN CA 15-3. Cancer / Oncology News From Medical News Today. Simple template. Powered by Blogger.
tumormarkers.blogspot.com
CANCER RESEARCH: Cancer Stem Cells in Pediatric Brain Tumors.
http://tumormarkers.blogspot.com/2009/06/cancer-stem-cells-in-pediatric-brain.html
Cancer Stem Cells in Pediatric Brain Tumors. Lasky JL 3rd, Choe M, Nakano I. Department of Neurosurgery, David Geffen School of Medicine at UCLA, USA. INakano@mednet.ucla.edu. Posted by Research Proteins. Massachusetts Institute Of Technology. Lee Biosolutions, Inc. CANCER ANTIGEN CA 125. CANCER ANTIGEN CA 50. CANCER ANTIGEN CA 72-4. CANCER ANTIGEN CA 15-3. Cancer / Oncology News From Medical News Today. Simple template. Powered by Blogger.
tumormarkers.blogspot.com
CANCER RESEARCH: Preoperative Ca-125 level predict optimal cytoreduction in patients with advanced ovarian carcinoma?
http://tumormarkers.blogspot.com/2009/01/can-preoperative-ca-125-level-predict.html
Preoperative Ca-125 level predict optimal cytoreduction in patients with advanced ovarian carcinoma? Level has been used as a predictor of optimal cytoreduction in advanced ovarian carcinoma. Yet, controversy exists regarding the ability of the tumor marker to predict optimal debulking and moreover of the proper cut-off limit to do so. METHODS: The preoperative Ca-125. CONCLUSIONS: Our data indicate that preoperative Ca-125. Department of Gynecology, Metaxa Memorial Cancer Hospital, Piraeus, Greece.